FLT3LG and neoplasm: The tumor cells produce several factors, such as VEGF, IL-6, and PGE2, to inhibit FLT3L activity and prevent cDC1, moDC, and pre-DC maturation, differentiation, and survival in the TME, causing an immunosuppressive environment for tumor progression [115, 116].